Inactive Instrument

Stemcell Holdings, Inc. Stock Other OTC

Equities

STMM

US85858N2027

Pharmaceuticals

Sales 2016 3.34M Sales 2017 6.18M Capitalization 1.64M
Net income 2016 1M Net income 2017 2M EV / Sales 2016 * -
Net cash position 2016 * - Net cash position 2017 * - EV / Sales 2017 * -
P/E ratio 2016 *
-
P/E ratio 2017 *
-
Employees -
Yield 2016 *
-
Yield 2017 *
-
Free-Float 0.95%
More Fundamentals * Assessed data
Dynamic Chart
Stemcell Holdings, Inc. is engaged in the regenerative medicine-related business, which provides technical assistance to the culturing, storing and delivery of stem cells, administrative and consulting services to clinics. The Company provides two options for stem cell regenerative therapy: autologous adipose derived mesenchymal stem cells (ADMSC) and natural killer cells (NK). The Company provides coordination services to facilitate its stem cell culturing business. Its coordination services include the introduction of patients to clinics, arranging patients’ schedules, and translating between patients and clinics. The Company offers Internet marketing services by providing search engine optimization for clinics. It also offers property and equipment rental services. The Company operates through its wholly owned subsidiary, Stemcell Co., Ltd.
More about the company